Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aquestive Therapeutics Inc (NQ: AQST )

4.170 +0.020 (+0.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,225
Open 4.180
Bid (Size) 4.210 (1)
Ask (Size) 4.300 (3)
Prev. Close 4.150
Today's Range 4.086 - 4.290
52wk Range 3.100 - 9.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aquestive Therapeutics to Participate in Three Investor Conferences in September
From GlobeNewswire News Releases
Aquestive Therapeutics Negotiates Six Month Extension to June 30, 2022 for Additional Libervant™ Related Capital Under Current Debt Agreement
From GlobeNewswire News Releases

Performance

YTD
-24.73%
-24.73%
1 Month
+12.40%
+12.40%
3 Month
+2.46%
+2.46%
6 Month
-19.34%
-19.34%
1 Year
-53.20%
-53.20%

More News

Read More
Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance
From GlobeNewswire News Releases
Aquestive Therapeutics to Report Second Quarter 2021 Financial Results and Recent Business Highlights on August 3 and Host Conference Call on August 4 at 8:00 a.m. ET
From GlobeNewswire News Releases
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film
From GlobeNewswire News Releases
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
From GlobeNewswire News Releases
4 Stocks to Watch During a Market Crash
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
From GlobeNewswire News Releases
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
From GlobeNewswire News Releases
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.